Scorpius Holdings' CDMO assets foreclosed Dec 10, 2025; $15.2M proceeds settle $30.2M debt

Scorpius Holdings, Inc.

Collateral agent foreclosed on substantially all non-cash assets (lab equipment $7.1M, leases, inventory) on Dec 10, 2025.
Proceeds of $15.2M applied to partially settle $30.2M secured debt; $14.9M debt remains after sale.
All CDMO employees terminated Dec 10, 2025; majority joined buyer Velocity Bioworks (Tivic Health subsidiary).
Pro forma total assets drop from $20.8M to $0.9M; accumulated deficit rises to $321.4M.
Pro forma net loss for nine months ended Sep 30, 2025 adjusted to $1.47M from $16.8M reported.

item 9.01 item 2.01 item 2.04

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001079973-26-000283
form_type: 8-K/A
ticker: null
cik: 0001476963
company_name: Scorpius Holdings, Inc.
filed_at: 2026-03-10T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.159540+00:00
generated_at: 2026-05-15T15:58:22.634129+00:00
sec_items: ["9.01", "2.01", "2.04"]
event_type: other_material
sentiment: negative
materiality_score: 0.95
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001079973-26-000283
json_url: https://secwatch.observer/filing/0001079973-26-000283.json
markdown_url: https://secwatch.observer/filing/0001079973-26-000283.md
text_url: https://secwatch.observer/filing/0001079973-26-000283.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1476963/000107997326000283/0001079973-26-000283-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1476963/000107997326000283/scpx_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001079973-26-000283

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.